Drug-penetration gradients associated with acquired drug resistance in patients with tuberculosis

Keertan Dheda, Laura Lenders, Gesham Magombedze, Shashikant Srivastava, Prithvi Raj, Erland Arning, Paula Ashcraft, Teodoro Bottiglieri, Helen Wainwright, Timothy Pennel, Anthony Linegar, Loven Moodley, Anil Pooran, Jotam G. Pasipanodya, Frederick A. Sirgel, Paul D. Van Helden, Edward K Wakeland, Robin M. Warren, Tawanda Gumbo

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Rationale: Acquired resistance is an important driver of multidrugresistant tuberculosis (TB), even with good treatment adherence. However, exactly what initiates the resistance and how it arises remain poorly understood. Objectives: To identify the relationship between drug concentrations and drug susceptibility readouts (minimuminhibitory concentrations [MICs]) in the TB cavity. Methods: We recruited patients with medically incurable TB who were undergoing therapeutic lung resection while on treatment with a cocktail of second-line anti-TB drugs. On the day of surgery, antibiotic concentrations were measured in the blood and at seven prespecified biopsy sites within each cavity. Mycobacterium tuberculosis was grown from each biopsy site,MICs of each drug identified, and whole-genome sequencing performed. Spearman correlation coefficients between drug concentration and MIC were calculated. Measurements and Main Results: Fourteen patients treated for a median of 13 months (range, 5-31 mo) were recruited. MICs and drug resistance-associated single-nucleotide variants differed between the different geospatial locations within each cavity, and with pretreatment and serial sputum isolates, consistent with ongoing acquisition of resistance. However, pretreatment sputum MIC had an accuracy of only 49.48% in predicting cavitary MICs. There were large concentration-distance gradients for each antibiotic. The location-specific concentrations inversely correlated with MICs (P,0.05) and therefore acquired resistance. Moreover, pharmacokinetic/pharmacodynamic exposures known to amplify drug-resistant subpopulations were encountered in all positions. Conclusions: These data inform interventional strategies relevant to drug delivery, dosing, and diagnostics to prevent the development of acquired resistance. The role of high intracavitary penetration as a biomarker of antibiotic efficacy, when assessing new regimens, requires clarification.

Original languageEnglish (US)
Pages (from-to)1208-1219
Number of pages12
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume198
Issue number9
DOIs
StatePublished - Nov 1 2018

Fingerprint

Drug Resistance
Tuberculosis
Pharmaceutical Preparations
Anti-Bacterial Agents
Sputum
Biopsy
Ambulatory Surgical Procedures
Mycobacterium tuberculosis
Therapeutics
Nucleotides
Pharmacokinetics
Biomarkers
Genome
Lung

Keywords

  • acquired drug resistance
  • drug gradient
  • lung cavity
  • sputum MIC
  • whole-genome sequencing

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine

Cite this

Drug-penetration gradients associated with acquired drug resistance in patients with tuberculosis. / Dheda, Keertan; Lenders, Laura; Magombedze, Gesham; Srivastava, Shashikant; Raj, Prithvi; Arning, Erland; Ashcraft, Paula; Bottiglieri, Teodoro; Wainwright, Helen; Pennel, Timothy; Linegar, Anthony; Moodley, Loven; Pooran, Anil; Pasipanodya, Jotam G.; Sirgel, Frederick A.; Van Helden, Paul D.; Wakeland, Edward K; Warren, Robin M.; Gumbo, Tawanda.

In: American Journal of Respiratory and Critical Care Medicine, Vol. 198, No. 9, 01.11.2018, p. 1208-1219.

Research output: Contribution to journalArticle

Dheda, K, Lenders, L, Magombedze, G, Srivastava, S, Raj, P, Arning, E, Ashcraft, P, Bottiglieri, T, Wainwright, H, Pennel, T, Linegar, A, Moodley, L, Pooran, A, Pasipanodya, JG, Sirgel, FA, Van Helden, PD, Wakeland, EK, Warren, RM & Gumbo, T 2018, 'Drug-penetration gradients associated with acquired drug resistance in patients with tuberculosis', American Journal of Respiratory and Critical Care Medicine, vol. 198, no. 9, pp. 1208-1219. https://doi.org/10.1164/rccm.201711-2333OC
Dheda, Keertan ; Lenders, Laura ; Magombedze, Gesham ; Srivastava, Shashikant ; Raj, Prithvi ; Arning, Erland ; Ashcraft, Paula ; Bottiglieri, Teodoro ; Wainwright, Helen ; Pennel, Timothy ; Linegar, Anthony ; Moodley, Loven ; Pooran, Anil ; Pasipanodya, Jotam G. ; Sirgel, Frederick A. ; Van Helden, Paul D. ; Wakeland, Edward K ; Warren, Robin M. ; Gumbo, Tawanda. / Drug-penetration gradients associated with acquired drug resistance in patients with tuberculosis. In: American Journal of Respiratory and Critical Care Medicine. 2018 ; Vol. 198, No. 9. pp. 1208-1219.
@article{0f5d2b0d3f2147a595577f8626be7b78,
title = "Drug-penetration gradients associated with acquired drug resistance in patients with tuberculosis",
abstract = "Rationale: Acquired resistance is an important driver of multidrugresistant tuberculosis (TB), even with good treatment adherence. However, exactly what initiates the resistance and how it arises remain poorly understood. Objectives: To identify the relationship between drug concentrations and drug susceptibility readouts (minimuminhibitory concentrations [MICs]) in the TB cavity. Methods: We recruited patients with medically incurable TB who were undergoing therapeutic lung resection while on treatment with a cocktail of second-line anti-TB drugs. On the day of surgery, antibiotic concentrations were measured in the blood and at seven prespecified biopsy sites within each cavity. Mycobacterium tuberculosis was grown from each biopsy site,MICs of each drug identified, and whole-genome sequencing performed. Spearman correlation coefficients between drug concentration and MIC were calculated. Measurements and Main Results: Fourteen patients treated for a median of 13 months (range, 5-31 mo) were recruited. MICs and drug resistance-associated single-nucleotide variants differed between the different geospatial locations within each cavity, and with pretreatment and serial sputum isolates, consistent with ongoing acquisition of resistance. However, pretreatment sputum MIC had an accuracy of only 49.48{\%} in predicting cavitary MICs. There were large concentration-distance gradients for each antibiotic. The location-specific concentrations inversely correlated with MICs (P,0.05) and therefore acquired resistance. Moreover, pharmacokinetic/pharmacodynamic exposures known to amplify drug-resistant subpopulations were encountered in all positions. Conclusions: These data inform interventional strategies relevant to drug delivery, dosing, and diagnostics to prevent the development of acquired resistance. The role of high intracavitary penetration as a biomarker of antibiotic efficacy, when assessing new regimens, requires clarification.",
keywords = "acquired drug resistance, drug gradient, lung cavity, sputum MIC, whole-genome sequencing",
author = "Keertan Dheda and Laura Lenders and Gesham Magombedze and Shashikant Srivastava and Prithvi Raj and Erland Arning and Paula Ashcraft and Teodoro Bottiglieri and Helen Wainwright and Timothy Pennel and Anthony Linegar and Loven Moodley and Anil Pooran and Pasipanodya, {Jotam G.} and Sirgel, {Frederick A.} and {Van Helden}, {Paul D.} and Wakeland, {Edward K} and Warren, {Robin M.} and Tawanda Gumbo",
year = "2018",
month = "11",
day = "1",
doi = "10.1164/rccm.201711-2333OC",
language = "English (US)",
volume = "198",
pages = "1208--1219",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "9",

}

TY - JOUR

T1 - Drug-penetration gradients associated with acquired drug resistance in patients with tuberculosis

AU - Dheda, Keertan

AU - Lenders, Laura

AU - Magombedze, Gesham

AU - Srivastava, Shashikant

AU - Raj, Prithvi

AU - Arning, Erland

AU - Ashcraft, Paula

AU - Bottiglieri, Teodoro

AU - Wainwright, Helen

AU - Pennel, Timothy

AU - Linegar, Anthony

AU - Moodley, Loven

AU - Pooran, Anil

AU - Pasipanodya, Jotam G.

AU - Sirgel, Frederick A.

AU - Van Helden, Paul D.

AU - Wakeland, Edward K

AU - Warren, Robin M.

AU - Gumbo, Tawanda

PY - 2018/11/1

Y1 - 2018/11/1

N2 - Rationale: Acquired resistance is an important driver of multidrugresistant tuberculosis (TB), even with good treatment adherence. However, exactly what initiates the resistance and how it arises remain poorly understood. Objectives: To identify the relationship between drug concentrations and drug susceptibility readouts (minimuminhibitory concentrations [MICs]) in the TB cavity. Methods: We recruited patients with medically incurable TB who were undergoing therapeutic lung resection while on treatment with a cocktail of second-line anti-TB drugs. On the day of surgery, antibiotic concentrations were measured in the blood and at seven prespecified biopsy sites within each cavity. Mycobacterium tuberculosis was grown from each biopsy site,MICs of each drug identified, and whole-genome sequencing performed. Spearman correlation coefficients between drug concentration and MIC were calculated. Measurements and Main Results: Fourteen patients treated for a median of 13 months (range, 5-31 mo) were recruited. MICs and drug resistance-associated single-nucleotide variants differed between the different geospatial locations within each cavity, and with pretreatment and serial sputum isolates, consistent with ongoing acquisition of resistance. However, pretreatment sputum MIC had an accuracy of only 49.48% in predicting cavitary MICs. There were large concentration-distance gradients for each antibiotic. The location-specific concentrations inversely correlated with MICs (P,0.05) and therefore acquired resistance. Moreover, pharmacokinetic/pharmacodynamic exposures known to amplify drug-resistant subpopulations were encountered in all positions. Conclusions: These data inform interventional strategies relevant to drug delivery, dosing, and diagnostics to prevent the development of acquired resistance. The role of high intracavitary penetration as a biomarker of antibiotic efficacy, when assessing new regimens, requires clarification.

AB - Rationale: Acquired resistance is an important driver of multidrugresistant tuberculosis (TB), even with good treatment adherence. However, exactly what initiates the resistance and how it arises remain poorly understood. Objectives: To identify the relationship between drug concentrations and drug susceptibility readouts (minimuminhibitory concentrations [MICs]) in the TB cavity. Methods: We recruited patients with medically incurable TB who were undergoing therapeutic lung resection while on treatment with a cocktail of second-line anti-TB drugs. On the day of surgery, antibiotic concentrations were measured in the blood and at seven prespecified biopsy sites within each cavity. Mycobacterium tuberculosis was grown from each biopsy site,MICs of each drug identified, and whole-genome sequencing performed. Spearman correlation coefficients between drug concentration and MIC were calculated. Measurements and Main Results: Fourteen patients treated for a median of 13 months (range, 5-31 mo) were recruited. MICs and drug resistance-associated single-nucleotide variants differed between the different geospatial locations within each cavity, and with pretreatment and serial sputum isolates, consistent with ongoing acquisition of resistance. However, pretreatment sputum MIC had an accuracy of only 49.48% in predicting cavitary MICs. There were large concentration-distance gradients for each antibiotic. The location-specific concentrations inversely correlated with MICs (P,0.05) and therefore acquired resistance. Moreover, pharmacokinetic/pharmacodynamic exposures known to amplify drug-resistant subpopulations were encountered in all positions. Conclusions: These data inform interventional strategies relevant to drug delivery, dosing, and diagnostics to prevent the development of acquired resistance. The role of high intracavitary penetration as a biomarker of antibiotic efficacy, when assessing new regimens, requires clarification.

KW - acquired drug resistance

KW - drug gradient

KW - lung cavity

KW - sputum MIC

KW - whole-genome sequencing

UR - http://www.scopus.com/inward/record.url?scp=85050748574&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050748574&partnerID=8YFLogxK

U2 - 10.1164/rccm.201711-2333OC

DO - 10.1164/rccm.201711-2333OC

M3 - Article

VL - 198

SP - 1208

EP - 1219

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 9

ER -